KEGG pathway, upregulated | Number DE Genes | Pathway Size | P Value |
  Cytokine-cytokine receptor interaction | 43 | 266 | 3.49e-12 |
  TNF signaling pathway | 24 | 111 | 3.05e-09 |
  Transcriptional misregulation in cancer | 24 | 180 | 5.72e-09 |
  HIF-1 signaling pathway | 20 | 113 | 4.57e-07 |
  Hematopoietic cell lineage | 16 | 87 | 5.84e-07 |
  NF-kappa B signaling pathway | 19 | 102 | 1.55e-06 |
  Jak-STAT signaling pathway | 22 | 155 | 2.24e-06 |
  Legionellosis | 13 | 59 | 1.05e-05 |
  PI3K-Akt signaling pathway | 37 | 353 | 6.29e-05 |
  MAPK signaling pathway | 28 | 257 | 2.57e-04 |
  Salmonella infection | 12 | 79 | 9.24e-04 |
  Malaria | 9 | 49 | 1.00e-03 |
  NOD-like receptor signaling pathway | 10 | 59 | 1.03e-03 |
  Rheumatoid arthritis | 12 | 84 | 1.60e-03 |
  Glycolysis/Gluconeogenesis | 9 | 65 | 2.19e-03 |
  Mineral absorption | 8 | 46 | 2.72e-03 |
  ECM-receptor interaction | 11 | 87 | 6.42e-03 |
  Tuberculosis | 18 | 177 | 6.45e-03 |
  Gap junction | 11 | 88 | 7.00e-03 |
  Axon guidance | 14 | 129 | 8.88e-03 |
  Arginine and proline metabolism | 8 | 56 | 9.30e-03 |
  Prion diseases | 6 | 35 | 9.77e-03 |
KEGG pathway, downregulated | Number DE Genes | Pathway Size | P Value |
  Osteoclast differentiation | 21 | 126 | 2.99e-06 |
  Terpenoid backbone biosynthesis | 7 | 21 | 7.30e-05 |
  Staphylococcus aureus infection | 11 | 52 | 7.61e-05 |
  Steroid biosynthesis | 6 | 17 | 1.71e-04 |
  NOD-like receptor signaling pathway | 10 | 59 | 2.51e-04 |
  Peroxisome | 12 | 81 | 1.18e-03 |
  PPAR signaling pathway | 12 | 81 | 1.18e-03 |
  Chagas disease (American trypanosomiasis) | 14 | 104 | 1.24e-03 |
  Biosynthesis of unsaturated fatty acids | 6 | 25 | 1.69e-03 |
  Leishmaniasis | 10 | 66 | 2.50e-03 |
  ABC transporters | 8 | 46 | 2.75e-03 |
  Axon guidance | 15 | 129 | 3.69e-03 |
  Leukocyte transendothelial migration | 14 | 121 | 5.16e-03 |
  Fc gamma R-mediated phagocytosis | 11 | 89 | 7.70e-03 |
  Pancreatic cancer | 9 | 67 | 9.02e-03 |